相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
Paolo Martelletti
JOURNAL OF HEADACHE AND PAIN (2018)
Polypharmacy Among Headache Patients: A Cross-Sectional Study
Anna Ferrari et al.
CNS DRUGS (2018)
Is Migraine Primarily a Metaboloendocrine Disorder?
Innocenzo Rainero et al.
CURRENT PAIN AND HEADACHE REPORTS (2018)
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Timothy J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2018)
The epidemiology of headache disorders: a face-to-face interview of participants in HUNT4
Knut Hagen et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: an observational study in a tertiary headache center
Marina de Tommaso et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Psychiatric comorbidities and photophobia in patients with migraine
Stefan Seidel et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Migraine and Cerebrovascular Atherosclerosis in Patients With Ischemic Stroke
Hendrikus J. A. van Os et al.
STROKE (2017)
Personalised Healthcare: The DiMA Clinical Model
Marina Borro et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2017)
H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine
Marina Borro et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2016)
Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations
Luana Lionetto et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Pharmacogenetic insights into migraine treatment in children
Giovanna Gentile et al.
PHARMACOGENOMICS (2014)
The omics in migraine
Luana Lionetto et al.
JOURNAL OF HEADACHE AND PAIN (2013)
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Craig Knox et al.
NUCLEIC ACIDS RESEARCH (2011)
Pharmacological approaches to managing migraine and associated comorbidities - Clinical considerations for monotherapy versus polytherapy
Stephen D. Silberstein et al.
HEADACHE (2007)
The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes
Bent H. Hellum et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome p450 3A4, 2D6, and 2C9
SH Yale et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2005)
Pharmacogenetics and herb-drug interactions:: experience with Ginkgo biloba and omeprazole
OQP Yin et al.
PHARMACOGENETICS (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract
C Gaudineau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The influence of St. John's wort on CYP2C19 activity with respect to genotype
LS Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Saint John's wort:: An in vitro analysis of P-glycoprotein induction due to extended exposure
MD Perloff et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)